Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Masaki, Hosoya"'
Autor:
Ayako Ura, Takuo Hayashi, Kazumasa Komura, Masaki Hosoya, Kazuya Takamochi, Eiichi Sato, Satomi Saito, Susumu Wakai, Takafumi Handa, Tsuyoshi Saito, Shunsuke Kato, Kenji Suzuki, Takashi Yao, the Tokyo Metropolitan Innovative Oncology Research Group (TMIG)
Publikováno v:
The Journal of Pathology: Clinical Research, Vol 10, Iss 1, Pp n/a-n/a (2024)
Abstract A limited number of patients with lung squamous cell carcinoma (SCC) benefit clinically from molecular targeted drugs because of a lack of targetable driver alterations. We aimed to understand the prevalence and clinical significance of lysi
Externí odkaz:
https://doaj.org/article/d74d3a6bf28241e39e1c5855f8cdaf80
Autor:
Kei Sano, Takuo Hayashi, Yoshiyuki Suehara, Masaki Hosoya, Kazuya Takamochi, Shinji Kohsaka, Satsuki Kishikawa, Monami Kishi, Satomi Saito, Fumiyuki Takahashi, Kazuo Kaneko, Kenji Suzuki, Takashi Yao, Muneaki Ishijima, Tsuyoshi Saito
Publikováno v:
The Journal of Pathology: Clinical Research, Vol 7, Iss 4, Pp 361-374 (2021)
Abstract There are multiple transcription start sites (TSSs) in agreement with multiple transcript variants encoding different isoforms of NKX2‐1/TTF‐1 (thyroid transcription factor 1); however, the clinicopathological significance of each transc
Externí odkaz:
https://doaj.org/article/a37ed340293a4b39bb7bcdb6d0c529c6
Autor:
MIN HAN, SHIGEO YAMAGUCHI, MAI ONISHI, TOMOAKI FUJII, MASAKI HOSOYA, XUAN WEN, HIDENORI KIDO, SHUNSUKE KATO
Publikováno v:
Anticancer Research. 42:2277-2288
Autor:
Takuo, Hayashi, Monami, Kishi, Kazuya, Takamochi, Masaki, Hosoya, Shinji, Kohsaka, Satsuki, Kishikawa, Ayako, Ura, Kei, Sano, Noriko, Sasahara, Yoshiyuki, Suehara, Fumiyuki, Takahashi, Tsuyoshi, Saito, Kenji, Suzuki, Takashi, Yao
Publikováno v:
HistopathologyReferences.
A distinct subset of lung adenocarcinomas (LADs), arising from a series of peripheral lung cells defined as the terminal respiratory unit (TRU), is characterised by thyroid transcription factor 1 (TTF-1) expression. The clinical relevance of transcri
Autor:
Kenta Mukaihara, Yu Tanabe, Daisuke Kubota, Keisuke Akaike, Takuo Hayashi, Kaoru Mogushi, Masaki Hosoya, Shingo Sato, Eisuke Kobayashi, Taketo Okubo, Youngji Kim, Shinji Kohsaka, Tsuyoshi Saito, Kazuo Kaneko, Yoshiyuki Suehara
Publikováno v:
PLoS ONE, Vol 12, Iss 9, p e0185321 (2017)
Alveolar soft part sarcoma (ASPS) is an extremely rare metastatic soft tissue tumor with a poor prognosis for which no effective systemic therapies have yet been established. Therefore, the development of novel effective treatment approaches is requi
Externí odkaz:
https://doaj.org/article/6a02b15d002a43a7a7446e74ed1ef6b7
Autor:
Norihiko Yokoyama, Masaki Hosoya, Kiichi Sugimoto, Makoto Takahashi, Ryoichi Tsukamoto, Kazuhiro Sakamoto, Shingo Kawano, Midori Fukaya, Hiromitsu Komiyama
Publikováno v:
Juntendo Medical Journal. 67:272-281
Autor:
Min, Han, Shigeo, Yamaguchi, Mai, Onishi, Tomoaki, Fujii, Masaki, Hosoya, Xuan, Wen, Hidenori, Kido, Shunsuke, Kato
Publikováno v:
Anticancer research. 42(5)
The TP53-signature is a multi-gene signature that can predict TP53 structural mutations. It has presented remarkable ability to predict the prognosis of early-stage breast cancer. However, some samples presented discordance with the signature status
Autor:
Masaki Hosoya, Katherine Czysz
Publikováno v:
Cells, Vol 5, Iss 4, p 46 (2016)
Despite continuous efforts to improve the process of drug discovery and development, achieving success at the clinical stage remains challenging because of a persistent translational gap between the preclinical and clinical settings. Under these circ
Externí odkaz:
https://doaj.org/article/ff514ffec2824bbd8c363c1f84805979
Autor:
Masaki Hosoya, Satsuki Kishikawa, Fumiyuki Takahashi, Kazuo Kaneko, Takashi Yao, Kenji Suzuki, Shinji Kohsaka, Muneaki Ishijima, Takuo Hayashi, Satomi Saito, Monami Kishi, Tsuyoshi Saito, Yoshiyuki Suehara, Kei Sano, Kazuya Takamochi
Publikováno v:
The Journal of Pathology: Clinical Research
The Journal of Pathology: Clinical Research, Vol 7, Iss 4, Pp 361-374 (2021)
The Journal of Pathology: Clinical Research, Vol 7, Iss 4, Pp 361-374 (2021)
There are multiple transcription start sites (TSSs) in agreement with multiple transcript variants encoding different isoforms of NKX2‐1/TTF‐1 (thyroid transcription factor 1); however, the clinicopathological significance of each transcript isof
Autor:
Tetsu Hayashida, Kaoru Mogushi, Chikamasa Yamashita, Kazuya Takakuwa, Tomoaki Fujii, Shunsuke Kato, Shigeo Yamaguchi, Tomomi Akita, Masaki Hosoya, Arina Yamanami, Min Han
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
Many driver pathways for cancer cell proliferation have been reported. Driver pathway activation is often evaluated based on a single hotspot mutation such as EGFR L858R. However, because of complex intratumoral networks, the impact of a driver pathw